Trial intelligence / Profile preview

Bone marrow mesenchymal stem cell transplantation in children with spinal cord injury without fracture

ChiCTR-TCH-11001421Phase 2Completed

Sponsor
Chinese People's Armed Police Force
Start
Aug 2011
Modality
Stem Cell Therapies → Cell Therapies
Countries
1
01

Overview

Phase 2, open-label trial of bone marrow mesenchymal stem cells in spinal cord injury without radiographic abnormality (SCIWORA) (2 cohorts), sponsored by Chinese People's Armed Police Force. Primary endpoint: Electrophysiology. Started Aug 2011; status: completed.

02

Drugs

bone marrow mesenchymal stem cells
03

Conditions

spinal cord injury without radiographic abnormality (SCIWORA)

Beyond the preview

Go deeper on ChiCTR-TCH-11001421.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TCH-11001421.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call